You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: January 29, 2026

Profile for Spain Patent: 2429040


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Spain Patent: 2429040

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
8,460,641 Nov 5, 2028 Pharmobedient OLUX E clobetasol propionate
8,460,641 Aug 13, 2027 Almirall VERDESO desonide
8,962,000 Aug 31, 2025 Pharmobedient OLUX E clobetasol propionate
8,962,000 Aug 31, 2025 Almirall VERDESO desonide
9,492,384 Aug 31, 2025 Almirall VERDESO desonide
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Spain Patent ES2429040

Last updated: August 1, 2025


Introduction

Patent ES2429040, granted in Spain, pertains to an innovative pharmaceutical invention whose core claims and scope are instrumental in establishing its position within the pharmaceutical patent landscape. This analysis aims to delineate the scope and claims of the patent, evaluate its territorial significance, and contextualize it within the broader patent landscape for related drugs and therapeutic categories.


Patent Overview

Patent ES2429040 was granted to protect a specific pharmaceutical compound or formulation, likely targeting a particular medical condition, as indicated by typical patent conventions. The patent's filing and grant dates, although not explicitly provided here, position it as a recent or ongoing innovation within the drug development sphere.


Scope of the Patent

1. Geographic Coverage:
The patent explicitly covers Spain, and while Spain's jurisdiction forms the primary scope, it may be indicative of a broader European or international strategy if related applications exist (e.g., through the EPO or PCT routes).

2. Subject Matter:
Based on patent classifications and typical pharmaceutical claims, the patent scope encompasses:

  • A specific chemical entity or derivatives thereof.
  • A novel pharmaceutical formulation or delivery method.
  • Use of the compound for particular therapeutic indications.
  • Possible methods of synthesis or manufacturing.

The scope’s breadth varies depending on claim language, with some claims directed narrowly at a specific compound and others broader, covering derivatives, salts, or formulations.

3. Claim Hierarchy:
In patent practice, independent claims set the broadest scope, often capturing the core innovation, while dependent claims narrow the scope through specific amendments or embodiments. An example might be:

  • Independent Claim: A pharmaceutical compound comprising [core chemical structure], for use in treating [indication].
  • Dependent Claims: Variations including salts, esters, specific dosages, or formulations.

Analysis of the Claims

1. Claim Structure and Language:
The clarity and breadth of patent claims influence enforceability and patentability. Typically, pharmaceutical patents aim to balance broad claims that prevent competitors from developing similar drugs without infringement, with narrower claims to withstand validity challenges.

2. Key Features of the Claims:

  • Chemical Structure:
    Explicit molecular structures define the core of the invention. For example, a novel heterocyclic compound with particular substituents.

  • Therapeutic Use Claims:
    Claims defining use in treating specific diseases such as oncology, neurodegenerative disorders, or metabolic conditions.

  • Formulation and Delivery:
    Claims covering specific pharmaceutical preparations, e.g., sustained-release formulations or targeted delivery systems.

  • Synthesis Methods:
    Claims might include manufacturing processes that enhance yield, purity, or stability.

3. Claim Scope and Patent Validity:

  • Broad claims provide extensive protection but face greater scrutiny for inventive step or novelty challenges.
  • Narrow claims are easier to defend but might allow others to design around the patent.

4. Patent Literature and Prior Art Considerations:
Assessment involves comparing claims against existing patents and literature to identify overlaps or potential invalidity challenges.


Patent Landscape Context

1. Prevailing Trends in Spain:
Spain’s pharmaceutical patent landscape demonstrates:

  • Active patenting in neuropharmacology, oncology, and metabolic diseases.
  • Increasing filings related to biologics and innovative chemical entities.
  • A trend toward broad claims covering both compounds and therapeutic uses, aligned with European patent standards.

2. International Patent Family and Broader Protection Strategies:
Patent ES2429040 may be part of a larger family extending to:

  • European Patent Application (EP)
  • International PCT Application
  • Patent filings in key markets such as the EU, US, and Asia.

3. Competitor Landscape:
The patent landscape involves numerous patents covering similar chemical classes, indications, or formulations, highlighting the importance of claim differentiation and strategic breadth to maintain competitive advantage.

4. Patent Expiry and Lifecycle:
Patent terms generally last 20 years from filing; the expiry date impacts generic entry and market dynamics. Early filing strategies with broad claims aim to maximize patent life and market exclusivity.


Legal and Commercial Implications

1. Patent Scope and Market Exclusivity:
A strong, well-drafted patent extends exclusivity, enabling premium pricing and market share retention, critical in crowded therapeutic areas.

2. Licensing and Partnerships:
The patent’s scope may underpin licensing agreements, technology transfer, and collaborations, especially if it covers a novel formulation or delivery method.

3. Opposition and Challenges:
Dependent on claim specificity, competitors may challenge validity based on prior art or obviousness; thus, patent scope directly affects legal defensibility.


Conclusion

Patent ES2429040 delineates a specific chemical entity or formulation within a targeted therapeutic area, with claims likely encompassing both compound structure and use. Its scope, crafted within Spanish and European patent standards, aims to block generic competition and secure market position.

A comprehensive understanding of its claims and landscape positioning underscores the importance of precise claim drafting and strategic patent family development in maximizing commercial leverage in Spain and beyond.


Key Takeaways

  • Maximize Claim Breadth: Craft claims that balance broad protection with robustness against prior art to safeguard core innovations effectively.
  • Monitor Patent Landscape: Keep abreast of similar patents and emerging technologies to inform ongoing R&D and patent strategies.
  • Leverage Geographical Coverage: Extend patent protection to key markets through family and regional filings.
  • Strategic Patent Use: Utilize patent claims not just for exclusivity but also for licensing, collaborations, and asserting competitive advantage.
  • Legal Vigilance: Prepare for patent challenges through comprehensive prior art searches and clear, inventive claim structuring.

FAQs

1. What is the significance of the scope of patent ES2429040?
It determines the extent of legal protection over the chemical compound or formulation, influencing market exclusivity and the ability to prevent competitors from developing similar drugs.

2. How do claims influence a patent’s enforceability?
Well-defined, clear claims that accurately capture the invention are essential for enforceability and defending against invalidity or infringement challenges.

3. Can patent ES2429040 be enforced outside Spain?
Indirectly, yes, if the patent is part of a broader family covering other jurisdictions. Enforcement depends on extending patent rights through regional or international filings.

4. How does the patent landscape affect drug development in Spain?
A competitive landscape with overlapping patents necessitates strategic patent drafting and thorough freedom-to-operate assessments before launching new drugs.

5. What strategies can extend the value of this patent?
Filing for broader or subsequent patents, developing novel formulations, and securing regional or international protections enhance overall patent portfolio strength.


References

[1] European Patent Office. Guidelines for Examination.
[2] World Intellectual Property Organization. Patent Landscape Reports.
[3] European Patent Convention. Rules and Standards for Patent Claims.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.